IFITM3 and COVID-19: From the PBMCs of influenza- and COVID-19–infected patients, MSC identified 2 platelet subpopulations expanded in patients with severe COVID-19—namely, CRBN/RBX1-high (M33) and IFITM3-high (M34) cells.